logo

For the Inventor, By the Inventor

Berlin, Germany

Lechoslaw Turski

This inventor holds 23 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Schering Aktiengesellschaft, Solvay Pharmaceuticals, Gmbh, Scnering Aktiengesellschaft. Active years: 1993-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lechoslaw Turski. Retrieved from https://idiyas.com/inventor/lechoslaw-turski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 87.0

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 61(Granted Patents)


Company Filing History:

goldMedal18 out of 1,409 
 
Schering Aktiengesellschaft
 patents
silverMedal4 out of 77 
 
Solvay Pharmaceuticals, Gmbh
 patents
bronzeMedal1 out of 1 
 
Scnering Aktiengesellschaft
 patent

Years Active: 1993-2008

Loading Chart...
Areas of Expertise:
Quinoxaline Derivatives
Beta-Carboline Compounds
Pharmaceutical Compositions
Tolerance Prevention
Withdrawal Symptoms
Receptor Antagonists
Imidazole Derivatives
Carboxylic Acid Derivatives
23 patents (USPTO):Explore Patents
1. 7452875 - Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them (2008-11-18),
2. 7427611 - Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them (2008-09-23),
3. 7410962 - Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them (2008-08-12),
4. 7262184 - Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them (2007-08-28),
5. 6288065 - Quinoxaline-carboxylic acid derivatives (2001-09-11),
6. 6191132 - Use of quisqualate receptor antagonists (2001-02-20),
7. 6143733 - Quinoxalinedione derivatives, their production and use in pharmaceutical (2000-11-07),
8. 6136805 - Quinoxaline dione derivatives, their production and their use in (2000-10-24),
9. 6057304 - Quinoxaline-phosphonic acid derivatives (2000-05-02),
10. 5955461 - Quinoxalinedione derivatives, their production and use in pharmaceutical (1999-09-21),
11. 5750526 - Pyrido �1,2,3-DE!quinoxaline derivatives, process for their production (1998-05-12),
12. 5750525 - Quinoxalinedione derivatives, their production and use in pharmaceutical (1998-05-12),
13. 5710138 - Benzo�f!quinoxalinedione derivatives, their production and use in (1998-01-20),
14. 5698555 - Hetaryloxy-.beta.-carbolines, their production and use in pharmaceutical (1997-12-16),
15. 5614509 - Pharmaceutical agents for preventing the development of tolerance during (1997-03-25),

Title: Lechoslaw Turski: Pioneering Inventor from Berlin

Introduction: Lechoslaw Turski is a renowned inventor based in Berlin, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Turski holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Turski has worked with leading research institutions and tech companies, playing a key role in developing cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Turski has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence that has led to the successful implementation of numerous projects.

Conclusion: Lechoslaw Turski's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…